HomeQuestion

Does the imaging finding of central necrosis of an adrenal tumor, biochemically confirmed as pheochromocytoma, increase the risk of malignancy?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

In patients with secondary adrenal insufficiency, when would you consider adding fludrocortisone to their steroid regimen?

How do you manage insomnia in a patient with Cushing syndrome, considering that elevated nighttime cortisol levels may contribute to their sleep disturbances?

For patients with adrenal insufficiency who are on hydrocortisone replacement, would you recommend stress doses to cover for minor procedures such as dental work or thyroid fine-needle aspiration biopsies?

Do you recommend surgery for large (>4 cm) high density (>20HU) non-secretory adrenal masses, that have been stable in size for long periods of time (>3 years) when reviewing prior imaging?

For a patient with a large pheochromocytoma, how would you evaluate for possible autonomous cortisol co-secretion prior to adrenalectomy to assess need for risk of glucocorticoid withdrawal postoperatively?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.